Section: Livestock Bacteria

Animal Bacterial Diseases: Comprehensive Reference for Veterinary Clinicians

Bacterial diseases represent a major cause of morbidity, mortality, and economic loss in livestock production systems worldwide. This reference provides veterinary clinicians with a structured overview of the most clinically significant bacterial pathogens affecting cattle, sheep, goats, swine, and poultry. The focus is on pathogenesis, clinical presentation, diagnostic approaches, and evidence-based control measures.

Gram-Positive Pathogens of Livestock

Clostridial Diseases

The genus Clostridium comprises obligate anaerobic, spore-forming, Gram-positive bacilli that produce potent exotoxins responsible for distinct clinical syndromes [1]. Spore resistance to environmental extremes and disinfectants facilitates long-term persistence on pastures and in soil [2].

Clostridium chauvoei causes blackleg in cattle, an acute, fatal myonecrosis. Spores ingested from contaminated soil germinate in muscle tissue following trauma or bruising, leading to toxin-mediated necrosis and gas production [3]. Clinical signs include severe lameness, crepitant swelling of large muscle groups, pyrexia, and sudden death. Diagnosis relies on characteristic gross lesions (dark, dry, spongy muscle with a rancid odor), fluorescent antibody testing of affected tissue, and anaerobic culture [4]. Vaccination with bacterin-toxoid preparations provides effective prophylaxis [5].

Clostridium perfringens type D causes enterotoxemia (pulpy kidney disease) in sheep, particularly in rapidly growing lambs on high-concentrate diets [6]. The epsilon toxin increases intestinal permeability, is absorbed systemically, and causes endothelial damage in the brain and kidneys [7]. Clinical signs range from sudden death to neurological dysfunction (opisthotonos, convulsions). Postmortem findings include bilateral renal cortical softening and cerebrospinal angiopathy [8]. Diagnosis is confirmed by detection of epsilon toxin in intestinal contents via ELISA or mouse neutralization test [9]. Control relies on vaccination of ewes and lambs with multivalent clostridial toxoids [10].

Clostridium perfringens type C causes hemorrhagic enteritis (struck) in adult sheep and lamb dysentery in neonates [11]. The beta toxin is trypsin-sensitive, explaining the higher susceptibility of young animals with low pancreatic protease activity [12]. Clinical signs include abdominal pain, bloody diarrhea, and rapid death. Diagnosis involves demonstration of beta toxin in intestinal contents [13]. Vaccination of pregnant dams provides passive immunity to offspring via colostrum [14].

Clostridium novyi causes black disease (infectious necrotic hepatitis) in sheep, a condition almost invariably associated with concurrent liver fluke (Fasciola hepatica) infection [15]. Spores germinate in anoxic hepatic tissue created by migrating flukes, and the alpha toxin produces massive hepatic necrosis and sudden death [16]. Diagnosis is based on finding characteristic liver lesions and demonstrating toxin in hepatic tissue [17]. Control requires integrated management of both clostridial vaccination and fluke control [18].

Staphylococcal and Streptococcal Infections

Staphylococcus aureus is a major cause of contagious mastitis in dairy cattle [19]. The organism produces a range of virulence factors including protein A, coagulase, hemolysins, and biofilm-forming exopolysaccharides that facilitate adherence to mammary epithelium and evasion of host defenses [20]. Subclinical infections are common, with intermittent shedding of high somatic cell counts in milk [21]. Diagnosis relies on bacterial culture of milk samples and molecular typing (spa typing, multilocus sequence typing) for epidemiological investigations [22]. Control strategies emphasize milking hygiene, culling of chronically infected cows, and dry cow antibiotic therapy [23].

Streptococcus agalactiae (Group B Streptococcus) is a contagious mastitis pathogen in cattle that resides exclusively in the mammary gland [24]. It is highly responsive to penicillin-based intramammary therapy, and eradication from a herd is feasible through blanket dry cow treatment and culling of refractory cases [25].

Streptococcus suis serotype 2 is a significant pathogen of swine, causing meningitis, arthritis, and septicemia in post-weaning piglets [26]. The organism colonizes the upper respiratory tract and tonsils of carrier pigs, with disease triggered by stress factors such as weaning, crowding, or poor ventilation [27]. Diagnosis is confirmed by bacterial isolation from cerebrospinal fluid or joint fluid and serotyping by coagglutination or PCR [28]. Autogenous vaccines are used in endemic herds, though serotype diversity limits cross-protection [29].

Gram-Negative Pathogens of Livestock

Pasteurellaceae

Mannheimia haemolytica is the primary bacterial agent in bovine respiratory disease complex (BRDC), a multifactorial syndrome involving viral predisposing infections (bovine herpesvirus-1, bovine respiratory syncytial virus, parainfluenza-3 virus) and environmental stressors [30]. The organism produces a leukotoxin (LktA) that specifically targets ruminant leukocytes and platelets, inducing inflammatory mediator release and pulmonary tissue necrosis [31]. Clinical signs include pyrexia, depression, nasal discharge, dyspnea, and auscultable lung consolidation [32]. Diagnosis is based on deep nasopharyngeal swab culture, transtracheal wash cytology and culture, and PCR detection of M. haemolytica DNA [33]. Antimicrobial susceptibility testing is critical due to emerging resistance to tetracyclines and macrolides [34]. Control involves multivalent viral vaccination, strategic metaphylaxis at feedlot arrival, and management of environmental stressors [35].

Pasteurella multocida causes fowl cholera in poultry and pneumonic pasteurellosis in cattle, sheep, and swine [36]. In poultry, capsular serotypes A and F are associated with acute septicemic disease characterized by sudden death, cyanosis, and petechial hemorrhages on the heart and liver [37]. In cattle, P. multocida is a component of BRDC, often acting as a secondary invader following viral infection [38]. Diagnosis is by bacterial culture and serotyping. Vaccination with bacterins or live attenuated strains is used in endemic poultry flocks [39].

Avibacterium paragallinarum is the etiological agent of infectious coryza in chickens, an acute upper respiratory disease characterized by facial edema, nasal discharge, and conjunctivitis [40]. The organism is a fastidious, NAD-dependent Gram-negative coccobacillus. Diagnosis requires isolation on chocolate agar or PCR detection [41]. Serovar diversity (A, B, C) complicates vaccine efficacy, and autogenous vaccines are often employed [42].

Enterobacteriaceae

Escherichia coli is a versatile pathogen in livestock, causing diverse clinical syndromes including neonatal diarrhea (enterotoxigenic E. coli, ETEC), colibacillosis in poultry (avian pathogenic E. coli, APEC), and mastitis in cattle [43]. ETEC strains express fimbrial adhesins (F4, F5, F41) that mediate intestinal colonization and produce heat-labile (LT) and heat-stable (ST) enterotoxins that induce secretory diarrhea [44]. APEC strains possess virulence genes associated with extraintestinal infection, including those encoding aerobactin, type 1 fimbriae, and colicin V [45]. Diagnosis involves bacterial culture, serotyping, and PCR detection of virulence-associated genes [46]. Control relies on hygiene, maternal vaccination (for ETEC), and antimicrobial therapy guided by susceptibility testing [47].

Salmonella enterica subspecies enterica includes numerous serovars pathogenic to livestock. Salmonella Typhimurium and Salmonella Dublin are common causes of enteritis and septicemia in cattle, while Salmonella Choleraesuis is host-adapted to swine [48]. The organism invades intestinal epithelial cells via type III secretion systems, survives within macrophages, and induces a strong inflammatory response [49]. Clinical signs include pyrexia, diarrhea (often hemorrhagic), dehydration, and abortion in pregnant animals [50]. Diagnosis is by fecal culture on selective media (e.g., brilliant green agar, xylose-lysine-deoxycholate agar) and serotyping [51]. Control involves biosecurity, vaccination, and antimicrobial therapy (fluoroquinolones, third-generation cephalosporins) with attention to public health implications of antimicrobial resistance [52].

Mycoplasmas

Mycoplasmas are cell wall-deficient bacteria that cause chronic, debilitating diseases in livestock. Mycoplasma bovis is a major cause of chronic pneumonia, arthritis, and otitis media in feedlot cattle [53]. The organism lacks a cell wall, rendering beta-lactam antibiotics ineffective, and exhibits intrinsic resistance to many antimicrobial classes [54]. Diagnosis is challenging due to fastidious growth requirements; PCR and serological assays (ELISA) are preferred [55]. Control relies on biosecurity, all-in/all-out management, and vaccination with autogenous or commercial bacterins [56].

Mycoplasma hyopneumoniae is the primary agent of enzootic pneumonia in swine, a chronic respiratory disease characterized by a dry, non-productive cough and reduced growth performance [57]. The organism adheres to ciliated respiratory epithelium via surface adhesins (P97, P102), causing ciliostasis and loss of mucociliary clearance [58]. Diagnosis is by PCR on bronchoalveolar lavage fluid or lung tissue, and serology [59]. Control involves vaccination (commercial bacterins reduce lung lesion severity but do not prevent colonization), antimicrobial metaphylaxis (tiamulin, tylvalosin), and management of air quality and stocking density [60].

Tick-Borne and Vector-Borne Bacterial Diseases

Anaplasma marginale causes bovine anaplasmosis, an infectious anemia characterized by intraerythrocytic rickettsial organisms [61]. Transmission occurs via ticks (primarily Rhipicephalus and Dermacentor spp.), mechanical vectors (biting flies, contaminated needles), and transplacentally [62]. Clinical signs include pyrexia, pallor, icterus, and weight loss. Diagnosis is by examination of Giemsa-stained blood smears, PCR, or competitive ELISA [63]. Control involves vector management, use of sterile needles, and vaccination with live or inactivated vaccines in endemic regions [64].

Anaplasma phagocytophilum infects granulocytes of cattle, sheep, and horses, causing tick-borne fever characterized by pyrexia, leukopenia, and immunosuppression predisposing to secondary infections [65]. Diagnosis is by PCR or serology. Tetracycline therapy is effective [66].

Borrelia anserina causes avian spirochetosis, an acute septicemic disease of poultry transmitted by the fowl tick Argas persicus [67]. Clinical signs include pyrexia, depression, green diarrhea, and sudden death. Diagnosis is by dark-field microscopy of blood smears or PCR [68]. Control focuses on tick eradication from poultry housing [69].

Diagnostic Approaches

A systematic diagnostic approach is essential for accurate identification and management of bacterial diseases in livestock. The following decision tree outlines the key steps.

flowchart TD
    A[Clinical Presentation] --> B{Acute Death?}
    B -->|Yes| C[Postmortem Examination]
    B -->|No| D[Clinical Examination & History]
    C --> E[Gross Lesions & Tissue Sampling]
    D --> F[Sample Collection]
    E --> G[Gram Stain & Cytology]
    F --> G
    G --> H{Culture & Isolation}
    H -->|Aerobic| I[Blood Agar, MacConkey Agar]
    H -->|Anaerobic| J[Cooked Meat Medium, Anaerobic Agar]
    H -->|Fastidious| K[Chocolate Agar, Mycoplasma Broth]
    I --> L[Biochemical Identification]
    J --> L
    K --> L
    L --> M[Antimicrobial Susceptibility Testing]
    L --> N["Molecular Confirmation (PCR, Sequencing")]
    M --> O[Therapeutic Decision]
    N --> O
    O --> P[Treatment & Control Measures]
    P --> Q[Monitoring & Prevention]

Sample selection is critical. For respiratory disease, deep nasopharyngeal swabs, transtracheal washes, or bronchoalveolar lavage fluid are preferred [70]. For enteric disease, fresh fecal samples or intestinal contents from euthanized animals are optimal [71]. For septicemic disease, aseptically collected blood, liver, and spleen are recommended [72].

Molecular diagnostics, particularly real-time PCR and 16S rRNA gene sequencing, have revolutionized veterinary bacteriology by enabling rapid, sensitive detection of fastidious or unculturable organisms [73]. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) provides rapid, cost-effective identification of bacterial isolates at the species level [74].

Antimicrobial Stewardship and Resistance

Antimicrobial resistance (AMR) in livestock-associated bacteria is a growing concern with implications for both animal and public health [75]. Methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL)-producing E. coli, and multidrug-resistant Salmonella are of particular importance [76]. Veterinary clinicians must adhere to principles of antimicrobial stewardship: culture and susceptibility testing before therapy, use of narrow-spectrum agents when possible, appropriate dosage and duration, and avoidance of prophylactic use of medically important antimicrobials [77].

Control and Prevention Strategies

Effective control of bacterial diseases in livestock requires an integrated approach combining vaccination, biosecurity, management practices, and targeted antimicrobial use [78]. Vaccination strategies include bacterins (killed whole-cell vaccines), toxoids (inactivated toxins), live attenuated vaccines, and subunit vaccines targeting specific virulence factors [79]. Biosecurity measures include quarantine of new arrivals, all-in/all-out production systems, cleaning and disinfection protocols, and control of vectors and wildlife reservoirs [80].

Conclusion

Bacterial diseases remain a significant challenge in livestock production, requiring veterinary clinicians to maintain a comprehensive understanding of pathogenesis, diagnostic methods, and control strategies. The integration of traditional bacteriological techniques with modern molecular diagnostics and a commitment to antimicrobial stewardship is essential for effective disease management and the preservation of antimicrobial efficacy.

References

[1] Songer JG. Clostridial enteric diseases of domestic animals. Clinical Microbiology Reviews. 1996;9(2):216-234.

[2] Quinn PJ, Markey BK, Leonard FC, et al. Veterinary Microbiology and Microbial Disease. 2nd ed. Wiley-Blackwell; 2011.

[3] Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Journal of Veterinary Diagnostic Investigation. 2008;20(3):253-265.

[4] Sasaki Y, Takikawa N, Kojima A, et al. Phylogenetic analysis of Clostridium chauvoei based on 16S rRNA gene sequences. Anaerobe. 2002;8(5):267-274.

[5] Titball RW. Clostridium perfringens vaccines. Vaccine. 2009;27(Suppl 4):D44-D47.

[6] Uzal FA, Vidal JE, McClane BA, et al. Clostridium perfringens toxins involved in mammalian enterotoxemias. Veterinary Microbiology. 2010;140(3-4):337-345.

[7] Finnie JW. Pathogenesis of brain damage produced in sheep by Clostridium perfringens type D epsilon toxin: a review. Australian Veterinary Journal. 2003;81(4):219-221.

[8] Buxton D, MacKenzie G, Brown D, et al. Pulpy kidney disease in lambs. Veterinary Record. 1981;108(22):474-476.

[9] Uzal FA, Kelly WR, Morris WE, et al. Comparison of four techniques for the detection of Clostridium perfringens type D epsilon toxin in intestinal contents. Journal of Veterinary Diagnostic Investigation. 2002;14(1):31-35.

[10] Lewis CJ. Control of clostridial diseases in sheep. In Practice. 2007;29(5):258-265.

[11] Niilo L. Clostridium perfringens type C enterotoxemia. Canadian Veterinary Journal. 1988;29(8):658-664.

[12] Lawrence G, Cooke R. Experimental pigbel: the production and pathology of necrotizing enteritis due to Clostridium welchii type C in the guinea-pig. British Journal of Experimental Pathology. 1980;61(3):261-271.

[13] Uzal FA, Songer JG. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Journal of Veterinary Diagnostic Investigation. 2008;20(3):253-265.

[14] Lewis CJ. Clostridial diseases. In: Aitken ID, ed. Diseases of Sheep. 4th ed. Blackwell Publishing; 2007:156-167.

[15] Bagadi HO, Sewell MM. A study of the role of liver flukes in the pathogenesis of black disease in sheep. Research in Veterinary Science. 1974;17(2):182-187.

[16] Coyle D, Ambrose N, O'Neill EJ, et al. Black disease in sheep: a review. Irish Veterinary Journal. 2004;57(9):533-538.

[17] Popoff MR. Purification and characterization of Clostridium novyi type A alpha toxin. Journal of Biological Chemistry. 1987;262(11):5157-5161.

[18] Taylor MA, Coop RL, Wall RL. Veterinary Parasitology. 4th ed. Wiley-Blackwell; 2016.

[19] Barkema HW, Schukken YH, Zadoks RN. Invited review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. Journal of Dairy Science. 2006;89(6):1877-1895.

[20] Foster TJ. Immune evasion by staphylococci. Nature Reviews Microbiology. 2005;3(12):948-958.

[21] Sears PM, McCarthy KK. Management and treatment of staphylococcal mastitis. Veterinary Clinics of North America: Food Animal Practice. 2003;19(1):171-185.

[22] Zadoks RN, van Leeuwen WB, Kreft D, et al. Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing. Journal of Clinical Microbiology. 2002;40(11):3894-3902.

[23] Bradley AJ. Bovine mastitis: an evolving disease. Veterinary Journal. 2002;164(2):116-128.

[24] Keefe GP. Streptococcus agalactiae mastitis: a review. Canadian Veterinary Journal. 1997;38(7):429-437.

[25] Erskine RJ, Eberhart RJ. Herd management of Streptococcus agalactiae mastitis. Veterinary Clinics of North America: Food Animal Practice. 1990;6(2):383-393.

[26] Gottschalk M, Segura M. The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Veterinary Microbiology. 2000;76(3):259-272.

[27] Staats JJ, Feder I, Okwumabua O, et al. Streptococcus suis: past and present. Veterinary Research Communications. 1997;21(6):381-407.

[28] Marois C, Bougeard S, Gottschalk M, et al. Multiplex PCR assay for detection of Streptococcus suis species and serotypes 2 and 1/2 in tonsils of live and dead pigs. Journal of Clinical Microbiology. 2004;42(7):3169-3175.

[29] Baums CG, Valentin-Weigand P. Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development. Animal Health Research Reviews. 2009;10(1):65-83.

[30] Griffin D. Economic impact associated with respiratory disease in beef cattle. Veterinary Clinics of North America: Food Animal Practice. 1997;13(3):367-377.

[31] Highlander SK. Molecular genetic analysis of virulence in Mannheimia (Pasteurella) haemolytica. Frontiers in Bioscience. 2001;6:D1128-D1150.

[32] Mosier DA. Bacterial pneumonia. Veterinary Clinics of North America: Food Animal Practice. 1997;13(3):483-493.

[33] Fulton RW, Confer AW. Laboratory diagnosis of bovine respiratory disease complex. Veterinary Clinics of North America: Food Animal Practice. 2012;28(1):1-17.

[34] Portis E, Lindeman C, Johansen L, et al. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex. Journal of Veterinary Diagnostic Investigation. 2012;24(3):535-544.

[35] Smith RA. Impact of disease on feedlot performance: a review. Journal of Animal Science. 1998;76(1):272-274.

[36] Harper M, Boyce JD, Adler B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters. 2006;265(1):1-10.

[37] Glisson JR, Hofacre CL, Christensen JP. Fowl cholera. In: Swayne DE, ed. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013:807-823.

[38] Dabo SM, Taylor JD, Confer AW. Pasteurella multocida and bovine respiratory disease. Animal Health Research Reviews. 2007;8(2):129-150.

[39] Rimler RB, Glisson JR. Fowl cholera. In: Calnek BW, ed. Diseases of Poultry. 10th ed. Iowa State University Press; 1997:143-159.

[40] Blackall PJ, Christensen H, Beckenham T, et al. Reclassification of Pasteurella gallinarum, [Haemophilus] paragallinarum, Pasteurella avium and Pasteurella volantium as Avibacterium gallinarum gen. nov., comb. nov., Avibacterium paragallinarum comb. nov., Avibacterium avium comb. nov. and Avibacterium volantium comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2005;55(1):353-362.

[41] Chen X, Zhang P, Blackall PJ, et al. Characterization of Avibacterium paragallinarum isolates from China by pulsed-field gel electrophoresis. Avian Diseases. 2010;54(1):35-40.

[42] Blackall PJ, Matsumoto M, Yamamoto R. Infectious coryza. In: Saif YM, ed. Diseases of Poultry. 11th ed. Iowa State Press; 2003:691-703.

[43] Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nature Reviews Microbiology. 2004;2(2):123-140.

[44] Nagy B, Fekete PZ. Enterotoxigenic Escherichia coli in veterinary medicine. International Journal of Medical Microbiology. 2005;295(6-7):443-454.

[45] Dho-Moulin M, Fairbrother JM. Avian pathogenic Escherichia coli (APEC). Veterinary Research. 1999;30(2-3):299-316.

[46] Johnson TJ, Wannemuehler Y, Doetkott C, et al. Identification of minimal predictors of avian pathogenic Escherichia coli virulence for use as a rapid diagnostic tool. Journal of Clinical Microbiology. 2008;46(12):3987-3996.

[47] Fairbrother JM, Nadeau E, Gyles CL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Animal Health Research Reviews. 2005;6(1):17-39.

[48] Uzzau S, Brown DJ, Wallis T, et al. Host adapted serotypes of Salmonella enterica. Epidemiology and Infection. 2000;125(2):229-255.

[49] Haraga A, Ohlson MB, Miller SI. Salmonellae interplay with host cells. Nature Reviews Microbiology. 2008;6(1):53-66.

[50] Wray C, Davies RH. Salmonella infections in cattle. In: Wray C, Wray A, eds. Salmonella in Domestic Animals. CABI Publishing; 2000:169-190.

[51] Waltman WD, Gast RK, Mallinson ET. Salmonellosis. In: Swayne DE, ed. Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013:677-736.

[52] Angulo FJ, Baker NL, Olsen SJ, et al. Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans. Seminars in Pediatric Infectious Diseases. 2000;11(2):131-138.

[53] Nicholas RA, Ayling RD. Mycoplasma bovis: disease, diagnosis, and control. Research in Veterinary Science. 2003;74(2):105-112.

[54] Gautier-Bouchardon AV, Ferre S, Le Grand D, et al. Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France. PLoS One. 2014;9(2):e87672.

[55] Sachse K, Salam HS, Diller R, et al. Use of a novel real-time PCR technique to monitor and quantitate Mycoplasma bovis infection in cattle herds with mastitis and respiratory disease. Veterinary Journal. 2010;186(3):299-303.

[56] Maunsell FP, Woolums AR, Francoz D, et al. Mycoplasma bovis infections in cattle. Journal of Veterinary Internal Medicine. 2011;25(4):772-783.

[57] Thacker EL. Mycoplasma hyopneumoniae infections in swine. Veterinary Clinics of North America: Food Animal Practice. 2004;20(2):315-330.

[58] Minion FC, Adams C, Hsu T. R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia. Infection and Immunity. 2000;68(5):3056-3060.

[59] Dubosson CR, Conzelmann C, Miserez R, et al. Development of two real-time PCR assays for the detection of Mycoplasma hyopneumoniae in clinical samples. Veterinary Microbiology. 2004;102(1-2):55-65.

[60] Maes D, Segales J, Meyns T, et al. Control of Mycoplasma hyopneumoniae infections in pigs. Veterinary Microbiology. 2008;126(4):297-309.

[61] Kocan KM, de la Fuente J, Blouin EF, et al. The natural history of Anaplasma marginale. Veterinary Parasitology. 2010;167(2-4):95-107.

[62] Aubry P, Geale DW. A review of bovine anaplasmosis. Transboundary and Emerging Diseases. 2011;58(1):1-30.

[63] Torioni de Echaide S, Knowles DP, McGuire TC, et al. Detection of cattle naturally infected with Anaplasma marginale in a region of endemicity by nested PCR


Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.